CN Patent

CN118382462A — Cnp缀合物的有效剂量

Assigned to Ascendis Pharma Endocrinology Division AS · Expires 2024-07-23 · 2y expired

What this patent protects

本发明涉及包含CNP缀合物或其药学上可接受的盐的单位剂型。

USPTO Abstract

本发明涉及包含CNP缀合物或其药学上可接受的盐的单位剂型。

Drugs covered by this patent

Patent Metadata

Patent number: CN118382462A
Jurisdiction: CN
Classification: —
Expires: 2024-07-23
Drug substance claim: No
Drug product claim: No
Assignee: Ascendis Pharma Endocrinology Division AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.